Side effects are comparable, though AOD 9604 has more clinical data supporting its safety profile
10.2147/DDDT.S82030 7 KeremiB.LohinaiZ.KomoraP.DuhajS.BorsiK.JobbaGy-OvariG.et al (2009)
Administration BPC-157 has been studied in animals via injection, oral, and topical routes
The authors themselves described it as a small preliminary study.[15] A 2025 pilot report described intravenous administration to two healthy adults at doses up to 20 mg, with no measurable changes in cardiac, hepatic, renal or thyroid biomarkers and no reported adverse effects.[16] Two individuals cannot characterise uncommon reactions, immunogenicity, long-term toxicity, reproductive safety or oncological risk
Single-entry and repeated-entry container considerations Sterile water labels describe a single-entry format, and some versions state that users should discard any unused amount after the first withdrawal
Complete your research protocol with these compounds